Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. ZYNAL TABLET 275 MG [SIN08637P]

ZYNAL TABLET 275 MG [SIN08637P]

Active ingredients: ZYNAL TABLET 275 MG

Last updated 26 October 2025

Product Info

ZYNAL TABLET 275 MG

[SIN08637P]

Product information

Active Ingredient and Strength

NAPROXEN SODIUM - 275 MG

Dosage Form

TABLET, FILM COATED

Manufacturer and Country

KOREAN DRUG CO LTD - KOREA, REPUBLIC OF

Registration Number

SIN08637P

Licence Holder

ZIWELL MEDICAL (S) PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

M01AE02

■ Indications :

Zynal is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, acute gout, and skeletal-muscle disorder. It is also indicated in the relief of mild to severe pain after operation or dental extraction and for the treatment of primary dysmenorrhea.

■ Dosage & Administration :

  1. For mild to severe pain after operation or dental extraction, skeletal-muscle pain, acute tendinitis, bursitis, and primary dysmenorrhea :
    The recommended starting dose is 2 tablets, followed by 1 tablet every 6 to 8 hours, as required. The total daily dose should not exceed 5 tablets.

  2. For rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis :
    The recommended dose in adults is 1~2 tablets, twice daily (morning and evening).

  3. For acute gout :
    The recommended starting dose is 3 tablets, followed by 1 tablet every 8 hours until the attack has subsided.

  4. For migraine :
    The recommended starting dose is 3 tablets, followed by 1~2 tablets per day, as required. The total daily dose should not exceed 5 tablets.

■ Contraindications :

The drug is contraindicated in patients who have had allergic reactions to Naproxen sodium.
It is also contraindicated in patients in whom aspirin or other nonsteroidal anti-inflammatory/analgesic drugs induce the symptoms of asthma, rhinitis, and nasal polyps.